Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Japanese (NIKKEI) Life Sciences Industry Analysis

UpdatedJan 20, 2025
DataAggregated Company Financials
Companies15
  • 7D-3.5%
  • 3M1.9%
  • 1Y-14.7%
  • YTD-2.7%

Over the last 7 days, the Life Sciences industry has dropped 3.5%, driven by declines from every company within the industry. However, the industry is down 15% over the past year. As for the next few years, earnings are expected to grow by 16% per annum.

Industry Valuation and Performance

Has the Japanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 20 Jan 2025JP¥159.0bJP¥62.0bJP¥440.7m17.5x360.9x2.6x
Wed, 18 Dec 2024JP¥159.5bJP¥62.0bJP¥440.7m16.4x361.8x2.6x
Fri, 15 Nov 2024JP¥157.3bJP¥62.6bJP¥1.3b19.6x117.9x2.5x
Sun, 13 Oct 2024JP¥149.4bJP¥61.5bJP¥1.8b17.5x81.2x2.4x
Tue, 10 Sep 2024JP¥155.2bJP¥61.6bJP¥2.1b18.5x75.1x2.5x
Thu, 08 Aug 2024JP¥137.2bJP¥61.8bJP¥3.2b20.9x42.4x2.2x
Sat, 06 Jul 2024JP¥164.7bJP¥61.8bJP¥3.2b26.1x50.9x2.7x
Mon, 03 Jun 2024JP¥161.8bJP¥61.8bJP¥3.3b25.1x49.4x2.6x
Wed, 01 May 2024JP¥183.4bJP¥62.3bJP¥3.3b14x55.7x2.9x
Fri, 29 Mar 2024JP¥234.2bJP¥155.4bJP¥8.6b14x27.2x1.5x
Sun, 25 Feb 2024JP¥231.3bJP¥155.3bJP¥8.7b14.7x26.6x1.5x
Tue, 23 Jan 2024JP¥223.3bJP¥167.1bJP¥8.5b15x26.3x1.3x
Thu, 21 Dec 2023JP¥227.7bJP¥167.1bJP¥8.5b15x26.8x1.4x
Sat, 18 Nov 2023JP¥232.3bJP¥168.1bJP¥9.1b14.8x25.5x1.4x
Mon, 16 Oct 2023JP¥232.4bJP¥179.3bJP¥12.8b14.6x18.2x1.3x
Wed, 13 Sep 2023JP¥263.9bJP¥179.3bJP¥12.8b16x20.6x1.5x
Fri, 11 Aug 2023JP¥272.4bJP¥180.0bJP¥13.7b18.3x19.9x1.5x
Sun, 09 Jul 2023JP¥280.9bJP¥178.5bJP¥16.2b17.1x17.3x1.6x
Tue, 06 Jun 2023JP¥288.9bJP¥178.3bJP¥16.2b17.2x17.8x1.6x
Thu, 04 May 2023JP¥288.7bJP¥174.9bJP¥16.5b16.6x17.5x1.7x
Sat, 01 Apr 2023JP¥306.1bJP¥171.9bJP¥13.3b17x23.1x1.8x
Mon, 27 Feb 2023JP¥315.1bJP¥171.6bJP¥13.2b17.3x23.8x1.8x
Wed, 25 Jan 2023JP¥294.5bJP¥166.1bJP¥16.2b15.6x18.2x1.8x
Fri, 23 Dec 2022JP¥293.6bJP¥166.1bJP¥16.2b15.8x18.1x1.8x
Sun, 20 Nov 2022JP¥318.4bJP¥165.5bJP¥16.0b15.5x19.9x1.9x
Tue, 18 Oct 2022JP¥317.9bJP¥160.1bJP¥12.4b16.4x25.7x2x
Thu, 15 Sep 2022JP¥341.9bJP¥159.7bJP¥12.3b19x27.9x2.1x
Sat, 13 Aug 2022JP¥311.2bJP¥160.1bJP¥12.9b18.3x24.2x1.9x
Mon, 11 Jul 2022JP¥278.3bJP¥152.8bJP¥10.9b17.5x25.6x1.8x
Wed, 08 Jun 2022JP¥261.0bJP¥152.7bJP¥10.9b17.9x24x1.7x
Fri, 06 May 2022JP¥245.7bJP¥152.3bJP¥11.4b20.3x21.6x1.6x
Sun, 03 Apr 2022JP¥249.3bJP¥144.9bJP¥10.6b21.7x23.5x1.7x
Tue, 01 Mar 2022JP¥241.7bJP¥144.7bJP¥10.5b19.3x23x1.7x
Thu, 27 Jan 2022JP¥235.6bJP¥136.0bJP¥6.8b19.7x34.9x1.7x
Price to Earnings Ratio

34.9x


Total Market Cap: JP¥235.6bTotal Earnings: JP¥6.8bTotal Revenue: JP¥136.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Life Sciences Industry Price to Earnings3Y Average 47.3x202320242025
Current Industry PE
  • Investors are optimistic on the Japanese Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 361x which is higher than its 3-year average PE of 47.3x.
  • The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 60% per year over the last three years,
  • Revenues have also declined 23% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-1.30%
Healthcare-1.26%
Life Sciences-3.49%
Clinical Research and Equipment-3.49%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4892 Cyfuse Biomedical K.KJP¥454.001.6%
+JP¥55.3m		-36.8%PS61.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

2370

JP¥35.00

MEDINET

7D

-2.8%

1Y

-20.5%

7079

JP¥3,370.00

WDB coco

7D

-3.4%

1Y

-27.2%

4880

JP¥778.00

CellSource

7D

-6.3%

1Y

-35.6%

2395

JP¥1,632.00

Shin Nippon Biomedical Laboratories

7D

-2.2%

1Y

-2.1%

Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

Jan 10
Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

4583

JP¥217.00

Chiome Bioscience

7D

-13.2%

1Y

50.7%

4572

JP¥272.00

Carna Biosciences

7D

-4.9%

1Y

-43.7%

7707

JP¥229.00

Precision System Science

7D

-6.1%

1Y

-3.8%

4892

JP¥454.00

Cyfuse Biomedical K.K

7D

1.6%

1Y

-36.8%

Is Cyfuse Biomedical K.K (TSE:4892) Using Too Much Debt?

Dec 04
Is Cyfuse Biomedical K.K (TSE:4892) Using Too Much Debt?

4570

JP¥443.00

Immuno-Biological Laboratories

7D

-5.9%

1Y

-6.7%